Brokerages Set Royalty Pharma plc (NASDAQ:RPRX) Price ... - ETF …
3 hours ago · NASDAQ:RPRX opened at $30.03 on Friday. The company has a market cap of $17.69 billion, a P/E ratio of 15.56, a P/E/G ratio of 4.36 and a beta of 0.47. The company has a debt-to-equity ratio of 0. ...
OFF
Brokerages Set Royalty Pharma Plc (NASDAQ:RPRX) Price ... - ETF …
2 weeks from now
3 hours ago · NASDAQ:RPRX opened at $30.03 on Friday. The company has a market cap of $17.69 billion, a P/E ratio of 15.56, a P/E/G ratio of 4.36 and a beta of 0.47. The company has a debt-to-equity ratio of 0. ...
etfdailynews.com
OFF
Analysts Set Royalty Pharma Plc (NASDAQ:RPRX) Price ... - ETF …
2 weeks from now
Dec 21, 2024 · Shares of RPRX opened at $24.92 on Wednesday. The stock has a 50 day moving average price of $26.43 and a 200 day moving average price of $27.15. Royalty …
etfdailynews.com
OFF
Royalty Pharma: Key Strategic Updates To Be Priced In
2 weeks from now
1 hour ago · Following our Strong Buy suggestion in early November 2024, Royalty Pharma plc (NASDAQ:RPRX) stock price increased by more than 16%, with a clear outperformance over …
seekingalpha.com
OFF
Royalty Pharma (NASDAQ:RPRX) Stock, Analyst Ratings, Price …
2 weeks from now
Royalty Pharma PLC has a consensus price target of $45.38 based on the ratings of 8 analysts. The high is $60 issued by Tigress Financial on April 6, 2023.The low is $28 issued by UBS on …
benzinga.com
OFF
Royalty Pharma Plc (NASDAQ:RPRX) Receives Consensus
2 weeks from now
Dec 18, 2024 · Citigroup lowered their price target on Royalty Pharma from $60.00 to $40.00 and set a "buy" rating for the company in a research note on Friday, October 25th. StockNews.com …
marketbeat.com
OFF
Here's What Analysts Are Forecasting For Royalty Pharma Plc …
2 weeks from now
May 12, 2024 · The analysts are definitely expecting Royalty Pharma's growth to accelerate, with the forecast 28% annualised growth to the end of 2024 ranking favourably alongside historical …
yahoo.com
OFF
Royalty Pharma (NASDAQ:RPRX) Raised To “Strong-Buy” At TD …
2 weeks from now
Dec 26, 2024 · Citigroup reduced their price target on shares of Royalty Pharma from $60.00 to $40.00 and set a “buy” rating on the stock in a research report on Friday, October 25th.
etfdailynews.com
OFF
Royalty Pharma’s Strategic Acquisition And Share ... - Markets Insider
2 weeks from now
1 day ago · TD Cowen analyst Michael Nedelcovych reiterated a Buy rating on Royalty Pharma (RPRX – Research Report) today and set a price target of $42.00. Discover outperforming …
businessinsider.com
OFF
Royalty Pharma Announces Transformative Step In Company’s …
2 weeks from now
4 days ago · The total transaction value of approximately $1.1 billion (based on the closing price of Royalty Pharma plc common stock of $26.20 on January 8, 2025), with the majority paid in …
royaltypharma.com
OFF
Royalty Pharma (NASDAQ:RPRX) Is Increasing Its Dividend To $0.22
2 weeks from now
2 days ago · The board of Royalty Pharma plc (NASDAQ:RPRX) has announced that the dividend on 10th of March will be increased to $0.22, which will be 4.8% higher than last year's …
simplywall.st
OFF
Traders Purchase High Volume Of Call Options On Royalty Pharma …
2 weeks from now
1 hour ago · A number of brokerages have recently commented on RPRX. Citigroup reduced their price target on shares of Royalty Pharma from $60.00 to $40.00 and set a “buy” rating for the …
etfdailynews.com
OFF
Royalty Pharma (RPRX) Stock Forecast And Price Target 2025
2 weeks from now
5 days ago · According to the 7 analysts' twelve-month price targets for Royalty Pharma, the average price target is $41.67. The highest price target for RPRX is $51.00, while the lowest …
marketbeat.com
OFF
Look Under The Hood: VTV Has 16% Upside - Nasdaq
2 weeks from now
1 day ago · Similarly, RPRX has 41.94% upside from the recent share price of $29.49 if the average analyst target price of $41.86/share is reached, and analysts on average are …
nasdaq.com
OFF
JPMorgan Chase & Co. Trims Stake In Royalty Pharma Plc …
2 weeks from now
Jan 7, 2025 · Royalty Pharma plc has a 12-month low of $24.05 and a 12-month high of $31.66. The firm has a market cap of $15.17 billion, a price-to-earnings ratio of 13.34, a PEG ratio of …
etfdailynews.com
OFF
Royalty Pharma Simplifies Corporate Structure With $1.1 Billion Deal
2 weeks from now
4 days ago · Tranche Update on Royalty Pharma plc's Equity Buyback Plan announced on March 28, 2023. Nov. 06: CI Royalty Pharma plc, Q3 2024 Earnings Call, Nov 06, 2024 Nov. 06: …
marketscreener.com
OFF
Royalty Pharma Unveils $3B Buyback Plan, Projects $1.6B Savings …
2 weeks from now
4 days ago · The total transaction value of approximately $1.1 billion (based on the closing price of Royalty Pharma plc common stock of $26.20 on January 8, 2025), with the majority paid in …
stocktitan.net
OFF
Royalty Pharma Plc (NASDAQ:RPRX) Raises Dividend To $0.22 Per …
2 weeks from now
4 days ago · Royalty Pharma plc (NASDAQ:RPRX) announced a quarterly dividend on Friday, January 10th. Shareholders of record on Friday, February 21st will be given a dividend of 0.22 …
marketbeat.com
OFF
Pallas Capital Advisors LLC Invests $2.36 Million In Royalty Pharma …
2 weeks from now
2 days ago · Citigroup dropped their price objective on Royalty Pharma from $60.00 to $40.00 and set a "buy" rating on the stock in a research note on Friday, October 25th. Finally, …
marketbeat.com
FAQs about Brokerages Set Royalty Pharma plc (NASDAQ:RPRX) Price ... - ETF … Coupon?
What is the target price for Royalty Pharma (RPRX)?
Is Royalty Pharma a good stock to buy?
Should you buy Royalty Pharma plc (RPRX)?
What is the average 1 year price target for Royalty Pharma?
How did Royalty Pharma's stock perform in 2024?
Why did Royalty Pharma (RPRX) increase its share price?
Install CouponFollow Extension on Chrome
Install the CouponFollow extension to search for discount codes when shopping the fastest!
Install CouponFollow Chrome Extension
Listing Store by Characters
